N&B

N.B.Medical is a Japan-based private medical device company developing next-generation neurovascular devices for cerebrovascular disease, particularly devices used in endovascular treatment of intracranial aneurysms. The company combines physical device engineering with an in-house computational modeling and simulation stack, AI-enabled documentation, and digital twin methods to accelerate design, testing, and regulatory preparation. Its technology base includes a unique hybrid-structure stent platform, in-house finite-element simulation tools, and a novel anti-thrombogenic coating intended to improve both thromboresistance and cell adhesion on implanted stents. N.B.Medical appears to be advancing toward clinical-trial readiness rather than commercial sales, with financing used to support product development, domestic clinical preparation, and future overseas expansion.